Skip to content
← Back to this collection

PUBLICATIONS · 19465418

The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2009 Aug
First author
Terpos E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Terpos E
      type
      Author
    2. name
      Sezer O
      type
      Author
    3. name
      Croucher PI
      type
      Author
    4. name
      García-Sanz R
      type
      Author
    5. name
      Boccadoro M
      type
      Author
    6. name
      San Miguel J
      type
      Author
    7. name
      Ashcroft J
      type
      Author
    8. name
      Bladé J
      type
      Author
    9. name
      Cavo M
      type
      Author
    10. name
      Delforge M
      type
      Author
    11. name
      Dimopoulos MA
      type
      Author
    12. name
      Facon T
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Terpos E
      type
      Author
    2. name
      Sezer O
      type
      Author
    3. name
      Croucher PI
      type
      Author
    4. name
      García-Sanz R
      type
      Author
    5. name
      Boccadoro M
      type
      Author
    6. name
      San Miguel J
      type
      Author
    7. name
      Ashcroft J
      type
      Author
    8. name
      Bladé J
      type
      Author
    9. name
      Cavo M
      type
      Author
    10. name
      Delforge M
      type
      Author
    11. name
      Dimopoulos MA
      type
      Author
    12. name
      Facon T
      type
      Author
    bibliography ids
    1. nci-bib-fd1f34ba4c799679570f843c
    book metadata
    content sha256
    c4f1c893a86a04d505730e83172655c807006fdc149bb59d478d5aa7cd06f66b
    document type
    citation
    dois
    1. 10.1093/annonc/mdn796
    electronic publication date
    display
    2009 May 22
    precision
    day
    year
    2009
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19465418
    immutable id
    pubmed:19465418@c4f1c893a86a04d505730e83172655c807006fdc149bb59d478d5aa7cd06f66b
    journal
    abbreviation
    Ann Oncol
    issn electronic
    1569-8041
    issn print
    0923-7534
    issue
    8
    name
    Annals of oncology : official journal of the European Society for Medical Oncology
    nlm unique id
    9007735
    pages
    1303-17
    volume
    20
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19465418
      provenance
      batch id
      4f803f1a8e7b4f56d2f1
      provider
      NCBI PubMed ESummary
      record sha256
      e58786e50b8688da77cbbdd2e5ff99d507307e80399f93d4dc6c4f7be4a5da92
      response sha256
      fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
      retrieved at
      2026-09-09T23:46:26.391289+00:00
      publication date
      display
      2009 Aug
      precision
      month
      year
      2009
      publication types
      1. Journal Article
      2. Practice Guideline
      3. Research Support, Non-U.S. Gov't
      4. Review
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19465418/
      title
      The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.

      Preserved source evidence · Not medical advice